⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL20489372 | 0.85 | — | — | |
| SCHEMBL2251688 | 0.83 | — | — | |
| SCHEMBL127445 | 0.67 | — | — | |
| Vinyl Ether SCHEMBL406230 | 0.64 | — | — | |
| SCHEMBL622200 | 0.62 | — | — | |
| SCHEMBL932289 | 0.61 | — | — | |
| Propene SCHEMBL22609030 | 0.59 | — | — | |
| SCHEMBL12126904 | 0.57 | — | — | |
| SCHEMBL15740691 | 0.57 | — | — | |
| SCHEMBL1230912 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260086097-A1 | N-TERMINAL MULTIFUNCTIONAL CONJUGATION OF PROTEINS AND PEPTIDES (FOR BIOSENSING) | Roswell Biotechnologies, Inc. (US) | 2026-03-26 | — | — | US | claimed |
| EP-4584585-A2 | N-TERMINAL MULTIFUNCTIONAL CONJUGATION OF PROTEINS AND PEPTIDES FOR BIOSENSING | Roswell ME Inc. (US) | 2025-07-16 | — | — | EP | claimed |
| WO-2024054632-A2 | N-TERMINAL MULTIFUNCTIONAL CONJUGATION OF PROTEINS AND PEPTIDES FOR BIOSENSING | Roswell ME Inc. (US) | 2024-03-14 | — | — | WO | claimed |
| CN-117417387-A | Synthesis method of nucleoside analogue | 苏州翔实医药发展有限公司 | 2024-01-19 | — | — | CN | claimed |
| WO-2023195929-A2 | BENCH-STABLE SULFONES AS GLYCOSYL DONORS FOR CARBOHYDRATE SYNTHESIS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-10-12 | — | — | WO | claimed |
| CN-112225729-A | Pyrimidine derivative, preparation method and application thereof and pharmaceutical composition | 四川大学华西医院 | 2021-01-15 | — | — | CN | claimed |
| US-20100228028-A1 | PROCESSES FOR THE MANUFACTURE OF ROSUVASTATIN AND INTERMEDIATES | ASTRAZENECA UK LIMITED (GB) | 2010-09-09 | — | — | US | claimed |
| EP-1904456-A1 | PROCESSES FOR THE MANUFACTURE OF ROSUVASTATIN AND INTERMEDIATES | AstraZeneca UK Limited (GB) | 2008-04-02 | — | — | EP | claimed |
| WO-2007007119-A1 | PROCESSES FOR THE MANUFACTURE OF ROSUVASTATIN AND INTERMEDIATES | ASTRAZENECA UK LIMITED (GB) | 2007-01-18 | — | — | WO | claimed |
| EP-4746911-A1 | PHOSPHORAMIDITE LINKERS | United Kingdom Research and Innovation (GB) | 2026-05-27 | — | — | EP | disclosed |
| US-12600698-B2 | Kinase inhibitors | VIDYA THERAPEUTICS, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| US-20260092040-A1 | SYNTHESIS OF CYCLOPROPANE CARBOXYLIC ACIDS | PAPAIOANNOU NIKOLAOS (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260086097-A1 | N-TERMINAL MULTIFUNCTIONAL CONJUGATION OF PROTEINS AND PEPTIDES (FOR BIOSENSING) | Roswell Biotechnologies, Inc. (US) | 2026-03-26 | — | — | US | disclosed |
| US-12583856-B2 | Inhibitors of protein kinase A | BLUEPRINT MEDICINES CORPORATION (US) | 2026-03-24 | — | — | US | disclosed |
| EP-1196436-A2 | PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE | Bristol-Myers Squibb Pharma Company (US) | 2002-04-17 | — | — | EP | disclosed |
| US-6222048-B1 | AS ANTIINFLAMMATORY, ANTIPYRETIC AND ANALGESIC AGENTS; INHIBITS HORMONE INDUCED UTERINE CONTRACTION; ANTICANCER PROPERTIES; SIDE EFFECT REDUCTION | MERCK FROSST CANADA & CO. (CA) | 2001-04-24 | — | — | US | disclosed |
| WO-2001007407-A1 | LACTAM INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001002424-A2 | PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE | DU PONT PHARMACEUTICALS COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| EP-0799218-A1 | DIARYL-2-(5H)-FURANONES AS COX-2 INHIBITORS | MERCK FROSST CANADA INC. (CA) | 1997-10-08 | — | — | EP | disclosed |
| WO-1996019469-A1 | DIARYL-2-(5H)-FURANONES AS COX-2 INHIBITORS | MERCK FROSST CANADA INC. (CA) | 1996-06-27 | — | — | WO | disclosed |